{"title": "For $323M, Samsung Biologics buys land for a 2nd manufacturing campus in South Korea", "author": "Kevin Dunleavy", "url": "https://www.fiercepharma.com/manufacturing/323-million-samsung-bio-buys-land-second-manufacturing-campus-south-korea", "hostname": "fiercepharma.com", "description": "Samsung's expansion plan for its CDMO unit is an efficient, no-nonsense enterprise, marching on with no end in sight. | Samsung has acquired additional land in Incheon, South Korea, on which to construct a new duplicate facility, Bio Campus II. The parcel was purchased for 426 billion won ($323 million) and is 30% larger than Samsung's original campus. By 2032, it will house 4,000 employees\u2014or roughly 400 new hires per year, Samsung said during a signing ceremony Monday at Incheon City Hall.", "sitename": "FiercePharma", "date": "2022-07-18", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}